Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haim Gutman

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of Medical Imaging and Radiation Oncology|November 17, 2018
MRI diagnosis and follow-up of chest wall and breast desmoid tumours in patients with a history of oncologic breast surgery and silicone implants: A pictorial reportAhuva Grubstein, Yael Rapson, Alona Zer, et al.
Oncology Reports|July 29, 2003
Variable cytotoxicity of amifostine in malignant and non-malignant cell linesBaruch Brenner, Lina Wasserman, Einat Beery, et al.
The American Journal of Dermatopathology|April 30, 2002
Relationship of tumorigenic malignant melanomas to dermal elastin: an expression of tumor/stromal interaction that may be related to prognosisMeora Feinmesser, Jacob M Schachter, Ana Tobar, et al.
Melanoma Research|August 12, 2004
Sentinel node guided surgery for melanoma in the head and neck regionThomas Shpitzer, Karl Segal, Jacob Schachter, et al.
Oncology Reports|October 10, 2003
Older age and second skin cancer as prognostic factors in localized malignant melanomasBaruch Brenner, Sara Borok, Erica Rakowsky, et al.
Oncology Reports|June 18, 2002
Basic fibroblast growth factor mediated growth inhibition in breast cancer cells is independent of ras signaling pathwayEyal Fenig, Martin Szyper-Kravitz, Rinat Yerushalmi, et al.
Oncology Reports|November 21, 2008
Concurrent chemobiotherapy with cisplatin, dacarbazine, decrescendo interleukin-2 and interferon alpha2b in patients with metastatic melanomaJair Bar, Rinat Yerushalmi, Roni Shapira-Frummer, et al.
The American Journal of Dermatopathology|June 19, 2010
Different patterns of expression of the erbB family of receptor tyrosine kinases in common nevi, dysplastic nevi, and primary malignant melanomas: an immunohistochemical studyMeora Feinmesser, Vladimir Veltman, Sara Morgenstern, et al.
Melanoma Research|November 10, 2007
Sentinel node-guided evaluation of drainage patterns for melanoma of the helix of the earThomas Shpitzer, Haim Gutman, Yoav Barnea, et al.
The Journal of Clinical Investigation|August 27, 2019
A distinct subset of FcγRI-expressing Th1 cells exert antibody-mediated cytotoxic activityDiana Rasoulouniriana, Nadine Santana-Magal, Amit Gutwillig, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Medical Imaging and Radiation Oncology|November 17, 2018
MRI diagnosis and follow-up of chest wall and breast desmoid tumours in patients with a history of oncologic breast surgery and silicone implants: A pictorial reportAhuva Grubstein, Yael Rapson, Alona Zer, et al.
Oncology Reports|July 29, 2003
Variable cytotoxicity of amifostine in malignant and non-malignant cell linesBaruch Brenner, Lina Wasserman, Einat Beery, et al.
The American Journal of Dermatopathology|April 30, 2002
Relationship of tumorigenic malignant melanomas to dermal elastin: an expression of tumor/stromal interaction that may be related to prognosisMeora Feinmesser, Jacob M Schachter, Ana Tobar, et al.
Melanoma Research|August 12, 2004
Sentinel node guided surgery for melanoma in the head and neck regionThomas Shpitzer, Karl Segal, Jacob Schachter, et al.
Oncology Reports|October 10, 2003
Older age and second skin cancer as prognostic factors in localized malignant melanomasBaruch Brenner, Sara Borok, Erica Rakowsky, et al.
Oncology Reports|June 18, 2002
Basic fibroblast growth factor mediated growth inhibition in breast cancer cells is independent of ras signaling pathwayEyal Fenig, Martin Szyper-Kravitz, Rinat Yerushalmi, et al.
Oncology Reports|November 21, 2008
Concurrent chemobiotherapy with cisplatin, dacarbazine, decrescendo interleukin-2 and interferon alpha2b in patients with metastatic melanomaJair Bar, Rinat Yerushalmi, Roni Shapira-Frummer, et al.
The American Journal of Dermatopathology|June 19, 2010
Different patterns of expression of the erbB family of receptor tyrosine kinases in common nevi, dysplastic nevi, and primary malignant melanomas: an immunohistochemical studyMeora Feinmesser, Vladimir Veltman, Sara Morgenstern, et al.
Melanoma Research|November 10, 2007
Sentinel node-guided evaluation of drainage patterns for melanoma of the helix of the earThomas Shpitzer, Haim Gutman, Yoav Barnea, et al.
The Journal of Clinical Investigation|August 27, 2019
A distinct subset of FcγRI-expressing Th1 cells exert antibody-mediated cytotoxic activityDiana Rasoulouniriana, Nadine Santana-Magal, Amit Gutwillig, et al.
Pageof 4